Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor-α inhibitors in clinical practice

Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor-α inhibitors in clinical practice

Yi-Hsing Chen,1 Hellen MDS de Carvalho,2 Umut Kalyoncu,3 Lyndon John Q Llamado,4 Gaston Solano,5 Ron Pedersen,6 Galina Lukina,7 Juan J Lichauco,8 Radu S Vasilescu9 1Division of Allergy, Immunology, and Rheumatology, Taichung Veterans General Hospital, Taichung City, Taiwan; 2Unidade de Reumatologia,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chen YH, Carvalho HMS, Kalyoncu U, Llamado LJQ, Solano G, Pedersen R, Lukina G, Lichauco JJ, Vasilescu RS
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Tuberculosis
hepatitis C
hepatitis B
tumor necrosis factor inhibitors
reactivation
risk
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/47bee8f6070247f79365ffbdb445e498
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/47bee8f6070247f79365ffbdb445e498

Ejemplares similares